Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Board/Management Information 2023

Oct 30, 2023

62616_rns_2023-10-30_a5df6efd-9799-4a39-b90a-1144180e7db3.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [128 x 42] intentionally omitted <==

October 30, 2023

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051

Scrip code: STAR

Dear Madam/ Sir,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/ HO/ CFD/ CFDPoD-1/ P/ CIR/ 2023/ 123 dated July 13, 2023

With reference to the above, we wish to inform you about the following change in Senior Management Personnel (SMP) of the Company:

  • 1) Resignation of Mr. Christoph Funke, Chief Operating Officer of the Company effective February 29, 2024;

  • 2) Appointment of Mr. Ramaraju PVS as the Chief Operating Officer of the Company effective March 1, 2024.

Ram will join the rolls of Strides effective November 1, 2023 and will work with Christoph to transition his role during the next 4 months.

Letter of resignation from Mr. Christoph Funke along with disclosures in the prescribed format is enclosed as an Annexure to this letter.

This is for your information and records.

Thanks & Regards, For Strides Pharma Science Limited,

MANJULA Digitally signed by MANJULA RAMAMURT RAMAMURTHY Date: 2023.10.30 HY 14:47:38 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No. A30515

Encl. As above

==> picture [479 x 53] intentionally omitted <==

==> picture [128 x 42] intentionally omitted <==

Annexure A

Resignation of Mr. Christoph Funke, Chief Operating Officer (COO) of the Company effective February 29, 2024

# Details Information of such event
1. Reasons for change, viz.,
~~appointment,~~resignation,
~~removal, death or otherwise~~
Resignation of Mr. Christoph Funke as COO of the Company.
2. Date of~~appointment/ re-~~
~~appointment/~~cessation~~and~~
~~term of appointment/ re-~~
~~appointment~~
Resignation is effective closing business hours of February 29,
2024.
3. Brief profile
(in case of appointment)
Not Applicable
4. Disclosure of
relationships between
directors (in case of
appointment of a director)
Not Applicable

==> picture [479 x 53] intentionally omitted <==

Annexure B

==> picture [128 x 42] intentionally omitted <==

Appointment of Mr. PVS Ramaraju as Chief Operating Officer (COO) of the Company effective March 1, 2024

# Details Information of such event
1. Reasons for change, viz.,
appointment~~, resignation,~~
~~removal, death or otherwise~~
Appointment of Mr. Ramaraju PVS (Ram) as the COO of the
Company effective March 1, 2024.
2. Date of appointment~~/ re-~~
~~appointment/ cessation~~and
term of appointment~~/ re-~~
~~appointment~~
Ram will join the rolls of Strides effective November 1, 2023
and will work with Christoph to transition his role during the
next four months.
3. Brief profile
(in case of appointment)
Ram has served in multiple leadership capacities in Strides
Pharma and later with Stelis Biopharma, primarily focusing on
quality and manufacturing Operations.
With thirty years of pharmaceutical industry experience, he has
dedicated over sixteen years to the Strides Group,
demonstrating a long-term commitment and amassing a wealth
of industry knowledge.
Throughout his illustrious career, he has also been associated
with reputable organizations like Dr. Reddy’s, USV and
Unichem.
Ram is a post-graduate in Pharmaceutical Chemistry from BITS
Pilani.
4. Disclosure of
relationships between
directors (in case of
appointment of a director)
Not Applicable

==> picture [479 x 53] intentionally omitted <==


From: Christoph Funke Christoph.Funke@strides.com Sent: 23 September 2023 00:01

To: Arun Kumar arun@strides.com Subject: CONFIDENTIAL

Dear Arun,

I am herewith tendering my resignation from my role as Chief Operations Officer at Strides Pharma Science Limited.

My last day of work will be during February 2024 as discussed earlier.

I am truly grateful for the opportunity you personally and the company have given me.

During my notice period, I will continue to support the business with my undivided focus and energy.

I wish you and the business success in the future.

Christoph

1